Pancreatic Cancer section

Prostate Cancer News & Features

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

Overall Survival Benefit With Prostate Cancer Vaccine Not Duplicated in Phase 3 Trial

Latest findings do not confirm an overall survival (OS) benefit found in a previous randomized phase 2 trial.

No Improvement in OS, DFS With MP + Adjuvant ADT for High-Risk Prostate Cancer

No Improvement in OS, DFS With MP + Adjuvant ADT for High-Risk Prostate Cancer

The addition of mitoxantrone and prednisone (MP) to adjuvant androgen-deprivation therapy did not increase survival among patients with high-risk prostate cancer.

Smoking During Primary Therapy Worsens Oncologic Outcomes in Prostate Cancer

Smoking During Primary Therapy Worsens Oncologic Outcomes in Prostate Cancer

A meta-analysis of 11 studies revealed the effects of smoking outcomes of primary radical radiotherapy or radical prostatectomy for prostate cancer.

ADT Affects Sexual Function, Intimacy in Early Prostate Cancer Treatment

ADT Affects Sexual Function, Intimacy in Early Prostate Cancer Treatment

Researchers report on a study investigating effects of ADT on prostate cancer health-related quality of life, sexual function, sexual bother, and mood for patients with prostate cancer and their partners.

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Drinking Wine in Moderation Does Not Appear to Impact Prostate Cancer Risk

Interestingly, red and white wine to not affect prostate cancer risk the same way.

USPSTF: Decision to Undergo PSA Screening Should Be Individual

USPSTF: Decision to Undergo PSA Screening Should Be Individual

The decision to undergo periodic PSA screening for prostate cancer should be an individual one for men aged 55 to 69 years, according to the recommendation statement.

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

Lower Disease-Specific Mortality Seen With Early Detection of Prostate Cancer

In an analysis of data from the SEER program, researchers determined that early detection of prostate cancer has let to an improvement in the number of men presenting with metastatic prostate cancer.

Challenges of Shared Decision Making in Prostate Cancer Screening

Challenges of Shared Decision Making in Prostate Cancer Screening

A review of shared decision making with men about undergoing PSA testing revealed that although full SDM discussions are increasing, variations in whether these discussions occur and how much information is shared still exist.

Long-term Prostate Cancer Risk Reduction Seen With Finasteride

Long-term Prostate Cancer Risk Reduction Seen With Finasteride 

Finasteride recipients had a 21.1% decreased risk of prostate cancer compared with placebo recipients, researchers found.

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

PSA Screening Increases Prostate Cancer Detection, No Significant Difference in Mortality

Researchers conducted a randomized clinical study of men to determine the impact of PSA screening on prostate cancer detection and mortality.

Prostate Cancer Resources

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs